chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Anion gap, Aspartate aminotransferase normal, Atelectasis
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basophil count decreased, Basophil percentage decreased, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bilirubin decreased
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine decreased, Blood glucose normal, Blood potassium normal
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium normal, Blood urea decreased, Blood urea nitrogen/creatinine ratio, C-reactive protein increased, COVID-19
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide increased, Chest X-ray abnormal, Differential white blood cell count, Eosinophil count decreased, Eosinophil percentage decreased
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Gastrostomy, Globulin, Haematocrit increased, Haemoglobin normal
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immature granulocyte count, Inflammatory marker increased, Lung opacity, Lymphocyte count, Lymphocyte percentage decreased
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume increased, Mean platelet volume increased, Monocyte count increased
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Monocyte percentage increased, Neutrophil count increased, Neutrophil percentage increased, Platelet count decreased, Pneumonia
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Protein total normal, Pyrexia, Red blood cell count normal, Red blood cell nucleated morphology, Red cell distribution width normal
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory symptom, SARS-CoV-2 test positive, Tachycardia, Upper respiratory tract congestion, White blood cell count increased
Clinical narrative: 1/20/22 16 yr/o female with a very complex medical history presented with URI symptoms and persistent fever in the setting of COVID was admitted for increasing oxygen requirements on the day of admission, close monitoring for possibility of decline given her complex medical history. 16 yr/o female who is a resident of (Privacy) with PMH of Extreme prematurity, Spastic quadriplegic CP, VP shunted hydrocephalus, dysphagia with GT, global developmental delay, chronic lung disease, epilepsy, hypothyroidism, hypercalcemia, optic atrophy presented with upper respiratory congestion and persistent fever in the setting of COVID infection (tested positive on 1/18/22) and unable to wean oxygen AM of the day of admission. She was admitted for increased oxygen requirement the same day morning of admission and close monitoring for possible decline given her complex history. The patients baseline is RA when awake and 2L or less when sleeping.Inflammatory marker CRP was high and CXR revealed developing right lower lobe/atelectasis. She required 2L NC admission morning at (Privacy), came to ED on 1L with oxygen saturation 99%, and saturating well on room air soon after while in ED. She was also tachycardic and appeared dry. Antibiotics (ampicillin) and IVF started. Closely monitored her vitals and pulse ox given her complex medical history and possibility of decline. Stable throughout hospitalization with no increased oxygen requirements. The patient was on room air during the day and used oxygen 2L NC only when asleep which is her baseline. She has been HDS, afebrile, at her baseline throughout. Contact and droplet precautions with eye protection   2. RLL Pneumonia CXR was suggestive of RLL Pneumonia/atelectasis done in the ED. Started ampicillin and switched to amoxicillin through G-tube after two days of clinical and laboratory improvement. The white counts and inflammatory markers downtrended throughout admission. Today is day 5 of antibiotics. Continue antibiotics for 2 more days through g-tube at (Privacy). (6 more doses). 1/24/2022 13:26
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Echocardiogram abnormal, Left ventricular dysfunction, Troponin increased
Clinical narrative: Chest pain, elevated troponin, LV wall motion abnormalities on ECHO.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, Dehydration, Fatigue
Clinical narrative: All over pain, fever,  joint pain.,Extreme exhaustion,  dehydration, lose of taste, lose of smell  Extra straights Tylenol alternating with ibuprofen. Symptoms continued through 2/1/2022. Had to work up endurance so I could return to work 2/2/2022 late light.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: All over pain, fever,  joint pain.,Extreme exhaustion,  dehydration, lose of taste, lose of smell  Extra straights Tylenol alternating with ibuprofen. Symptoms continued through 2/1/2022. Had to work up endurance so I could return to work 2/2/2022 late light.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Rash, Skin discolouration
Clinical narrative: Patient has developed a rash on his left wrist/hand/knuckle area which has become very red/purple, tingling, and stings
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy kidney, Chronic kidney disease, Renal disorder, Renal function test abnormal
Clinical narrative: Nephrology Dr: Diagnosed with acute kidney disease in August, I had to be hospitalized for 11 days, as the doctors figured out what the issue was (no family background of kidney issues). After 2 months it was downgraded to chronic kidney disease. Currently preparing for a kidney transplant.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Electrocardiogram, Laboratory test normal
Clinical narrative: STEMI
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypoxia
Clinical narrative: History obtained. Client went to the ER on 11/18/2021 after being diagnosed with Covid on 11/15/2021 with hypoxia and a cough. Her sats were in the 60s on arrival on room air.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic spontaneous urticaria
Clinical narrative: Chronic spontaneous urticaria.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure acute, Left ventricular failure
Clinical narrative: Acute on chronic systolic heart failure. ED visit to hospital admission, This visit was within 6 weeks of receiving the COVID vaccine.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: On 02/15/2021 I had a rash on my arms and legs, I had itchy bumps all over my arms and leg. I called my doctor and was prescribed Medrol pack. The rash lasted a week and was gone.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received booster dose at the 4.5 month mark as opposed to the 5 month mark. Patient is not immunocompromised therefore the spacing between doses should have been 5 months or more.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Central venous catheterisation, Device related infection
Clinical narrative: Infection of central venous catheter. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Age: 55.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: None, patient was physically fine and expressed no pain or discomfort after vaccination. Patient was accidentally given a second Pfizer booster when it should have been a Flu vaccine. Patient was informed of the misdose and then still consented and received the Flu vaccine in the same arm, per request, after the Pfizer dose.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: My father got his first Moderna shot from a pharmacy and had an injection site reaction to left arm started itching and then bumps appeared and then stopped.  Went back for second shot and same thing occurred and resolved. Then went to go get the booster made the two RN's aware had injection site reaction with itching and bumps both times. Was advised that it was okay to continue with his booster.  Was given his booster at hospital on 12/9/2021 and had the same itching and bumpy reaction. But now ever since then he has had issue with systemic spontaneous really bad itching and bumps
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine, Death, Full blood count
Clinical narrative: Resident  was hospice and expired
Age: 57.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expired vaccine was administered. Patient reports no adverse effects.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Chest pain, Headache, Hypertension, Injection site pain
Clinical narrative: SKIN RASH, BLOOD PRESSURE HIGHER THAN NORMAL, SUGAR HIGHER THAN NORMAL,  PULLED MUSCLE IN THE STOMACH, CHEST PAINS, BLURRED VISION. HEART PALPITATIONS,  SWELLING IN THE ANKLES AND HEADACHS, TROUBLE SLEEPING HANDS LOCK UP WITH PAIN, THROBING PAIN THROUGHOUT MY WHOLE BODY, PAIN IN THE INJECTION SITE.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Joint lock, Joint swelling, Muscle strain, Pain
Clinical narrative: SKIN RASH, BLOOD PRESSURE HIGHER THAN NORMAL, SUGAR HIGHER THAN NORMAL,  PULLED MUSCLE IN THE STOMACH, CHEST PAINS, BLURRED VISION. HEART PALPITATIONS,  SWELLING IN THE ANKLES AND HEADACHS, TROUBLE SLEEPING HANDS LOCK UP WITH PAIN, THROBING PAIN THROUGHOUT MY WHOLE BODY, PAIN IN THE INJECTION SITE.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Palpitations, Rash, Vision blurred
Clinical narrative: SKIN RASH, BLOOD PRESSURE HIGHER THAN NORMAL, SUGAR HIGHER THAN NORMAL,  PULLED MUSCLE IN THE STOMACH, CHEST PAINS, BLURRED VISION. HEART PALPITATIONS,  SWELLING IN THE ANKLES AND HEADACHS, TROUBLE SLEEPING HANDS LOCK UP WITH PAIN, THROBING PAIN THROUGHOUT MY WHOLE BODY, PAIN IN THE INJECTION SITE.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered BUD
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture, Blood glucose, Blood lactate dehydrogenase, Blood lactic acid, Chest X-ray abnormal
Clinical narrative: Patient presents to the ED on01/20/22 with a Chief Complaint of Shortness of Breath after receiving covid vaccine 01/10/2022. Per guidelines, all hospitalizations are reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram ST segment normal, Electrocardiogram T wave normal, Electrocardiogram normal, International normalised ratio normal
Clinical narrative: Patient presents to the ED on01/20/22 with a Chief Complaint of Shortness of Breath after receiving covid vaccine 01/10/2022. Per guidelines, all hospitalizations are reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Left ventricular hypertrophy, Lung opacity, Pneumonia, Procalcitonin, Prothrombin time normal
Clinical narrative: Patient presents to the ED on01/20/22 with a Chief Complaint of Shortness of Breath after receiving covid vaccine 01/10/2022. Per guidelines, all hospitalizations are reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: QRS axis normal, Troponin I normal, Urine analysis
Clinical narrative: Patient presents to the ED on01/20/22 with a Chief Complaint of Shortness of Breath after receiving covid vaccine 01/10/2022. Per guidelines, all hospitalizations are reported.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given 2 days past 10 week expiration date.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 30 days after I got my 2nd dose vaccination I contracted COVID 19 and it was my assessment that the vaccine weakens my immune system because from previous experience with the 1st dose I got bronchitis. I was a completely healthy person before getting vaccinated.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Death, Hypotension, Oxygen saturation decreased
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/27/2021 and 3/27/2021. Patient presented to ED for respiratory distress. Patient DNI on arrival and transitioned to DNR/COT. Patient received dexamethasone, zosyn, and remdesivir with plans to transfer home for hospice in the morning. Patient required BiPAP and became hypotensive. Patient desaturated and decompensated upon trying to transfer home. Patient expired 1/21/2022 at 1945.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Positive airway pressure therapy, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/27/2021 and 3/27/2021. Patient presented to ED for respiratory distress. Patient DNI on arrival and transitioned to DNR/COT. Patient received dexamethasone, zosyn, and remdesivir with plans to transfer home for hospice in the morning. Patient required BiPAP and became hypotensive. Patient desaturated and decompensated upon trying to transfer home. Patient expired 1/21/2022 at 1945.
Age: 4.0
Sex: M
Vaccine: DTAPHEPBIP, DTAPIPV
Symptoms: Extra dose administered
Clinical narrative: Patient was given two doses of DTAP and IPV on same day. No signs or symptoms at time of vaccination today around 2 pm. Follow up phone call with mother at 5 pm, child without signs or symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Arthralgia, Polyarthritis, Pulmonary embolism, Red blood cell sedimentation rate increased
Clinical narrative: 7/2021 started having severe joint pain, tenosynovitis, high sed rate, steroid repsonsive but symptoms worsened. Diagnosed with RA and started on Enbrel but not improving. 2/2/2022 presented to ER with acute worsening of polyarthrtis, diagnosed with multiple PE's on chest CT.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rheumatoid arthritis, Tenosynovitis
Clinical narrative: 7/2021 started having severe joint pain, tenosynovitis, high sed rate, steroid repsonsive but symptoms worsened. Diagnosed with RA and started on Enbrel but not improving. 2/2/2022 presented to ER with acute worsening of polyarthrtis, diagnosed with multiple PE's on chest CT.
Age: 66.0
Sex: F
Vaccine: FLUA4, VARZOS
Symptoms: Injection site pain
Clinical narrative: Prolonged muscle soreness at injections site, present now for three weeks, slowly improving.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given 2 days past the 10 week expiration date.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: On 09/27/2021, pt entered our facility and reported receiving unknown COVID vaccine. Per P&P, Intake RN placed an order to "review for COVID 19 Vaccination." On 10/16/2021, staff RN completed the order prior to confirming vaccination information.  On 01/28/2022, pt. placed a sick call slip "requesting to get a COVID shot."  Staff RN placed an order to "Administer COVID 19 Vaccine Order" per our P&P.  On 02/02/2022, pt received Moderna 0.5 dose to left arm, monitored for 15 minutes with no adverse reaction.  It was later identified that the patient had already received 1st and 2nd doses of vaccines while in the process of inputting COVID-19 vaccination information in the system.  Immediately,  pt. was re-evaluated with no s/s of adverse effects r/t to the vaccine and confirmation received that his intention was to receive a booster. Action Plan:  To review all patients COVID vaccination history/status in the system prior to placing order/administering COVID-19 vaccines. We will update our current COVID-19 vaccination consent to include the question, "Have you received a COVID-19 vaccination."
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered, No adverse event
Clinical narrative: There was no adverse event,  Patient received 2 doses of Shingrix.  We looked, no vaccines reported. Patient stated he received one dose on Shingrix in October of 2021, thus are dose was his third.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pfizer Covid-19 Vaccine EUA
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Flushing, Loss of consciousness, Pruritus
Clinical narrative: patient is observed for 60 min after administration with LVN, RN and MD. patient reports itching, feeling "flushed", and dizziness. Patient then given famotidine 20mg po and tylenol 650mg PO. Patient loses consciousness and code MET is called. patient is then transported to ER via gurney.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Loss of consciousness, Pruritus
Clinical narrative: patient is observed for 60 min after administration with LVN, RN and MD. patient reports itching, feeling "flushed", and dizziness. Patient then given famotidine 20mg po and tylenol 650mg PO. Patient loses consciousness and code MET is called. patient is then transported to ER via gurney.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic valve thickening, Ejection fraction, Fall, Left ventricular hypertrophy, Mitral valve incompetence
Clinical narrative: Patient was admitted to the Medical Center on 01/07/2022 under care of hospitalist service Dr. after an fall.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mitral valve thickening, Pulmonary hypertension, Pulmonary valve incompetence, Tricuspid valve incompetence
Clinical narrative: Patient was admitted to the Medical Center on 01/07/2022 under care of hospitalist service Dr. after an fall.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received Pfizer COVID-19 vaccine which was beyond the manufacturer recommended use time of 31 days at the refrigerated temperature. Organization has been in direct contact with the vaccine manufacturer regarding this issue. Pfizer has data to support the stability of the vaccine up to 45 days at refrigerated temperatures. The vaccine given was within this range which is supported by the above data. No known adverse outcomes.
Age: 55.0
Sex: F
Vaccine: FLUR4, VARZOS
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: Severe shivering 10 hours after shot. Nausea 8 - 20 hours after shot. Headache 10 - 24 hours after shot. Fatigue 8 - 40 hours after shot.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Eczema, Pruritus, Rash macular
Clinical narrative: Eczema flared up immensely. Multiple areas, large blotches, very itchy.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Confusional state, Unresponsive to stimuli
Clinical narrative: Patient found confused and unresponsive and brought to the ED.  Patient was admitted with Covid.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Chest X-ray, Computerised tomogram head, Decreased appetite
Clinical narrative: Severe calf pain, exhaustion, joint pain, headaches, nausea, loss of appetite, vision changes ,general feeling. Of being flulike    Since august 18. Still continuing
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Nausea, Pain in extremity
Clinical narrative: Severe calf pain, exhaustion, joint pain, headaches, nausea, loss of appetite, vision changes ,general feeling. Of being flulike    Since august 18. Still continuing
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Visual impairment
Clinical narrative: Severe calf pain, exhaustion, joint pain, headaches, nausea, loss of appetite, vision changes ,general feeling. Of being flulike    Since august 18. Still continuing
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle spasms
Clinical narrative: patient reports 2 weeks after receiving  2nd shot he starting having cramping in hands and feet.  Also started having whole body joint pain.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Rash, Rash macular, Scab
Clinical narrative: About 1-2 weeks after the second dose the client stated she developed the same rash and it lasted one month. The client has reported intermittent recurrence of the red patches since receiving the second vaccine. She states the patches scab over and take a while to heal. The client used an over the counter topical cream on the rash. Client also reported onset of muscle cramps and headache 3 hours after both doses of the vaccine that lasted 3 days. Client denied any dizziness or shortness of breath after either dose of COVID vaccine. The client reports a history of fibromyalgia controlled with over the counter pain medications. The client reports a history of anaphylaxis after taking penicillin. The client stated she cannot take aspirin due to ulcers.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: partial dose accidently given. Parents refused immediate repeat of dose per cdc guidance.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient came in today for their appointment for their second dose of Moderna. Patient was screened and immunized by one of our nurses. According to the patient's CDC card, they received their first dose of Moderna on 1/13 and therefore they got their second dose 1 week too early. Per CDC, a second dose given earlier than the minimum interval allowed (i.e., sooner than the 4-day grace period) is considered invalid and should be repeated no sooner than either 21 days (Pfizer-BioNTech COVID-19 Vaccine formulation) or 28 days (Moderna COVID-19 Vaccine) following the invalid second dose in order to complete the primary series. Patient was counseled and an appointment was made for March 3rd. Patient felt fine after their waiting period.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever-101.6; nausea/vomiting, muscle aches
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope
Clinical narrative: PT. FAINTED APROX 3 MINS AFTER RECEIVING COVID-19 VACCINE, SHE FELT DIZZY AND SAT IN CHAIR, FAINTED FOR ABOUT 3 SECONDS, EMTS CALLED EVAULUATED PT, LEFT UNDER OWN WILLPOWER WITH MOTHER AND SISTER
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Within minutes of getting vaccine complained of headache and dizziness. Watched in clinic for an extra half an hour, was stable no other complaints, thought he was feeling better so sent home. Parent and parent returned to UC on 1/19 reporting that headache continued for several day and was intermittent after that. But still happening most days. Better with Tylenol of ibuprofen, but dad was using sparingly.  Had follow up in pediatrics on 2/2. Dad reports headaches are improving  in frequency and severity But patient still complains 2-3 times a week. Mostly seems to complain during school or homework so dad is not sure if he is having pain or if it is behavioral. Is concerned as this is not a symptom he had previous to vaccine and the symptoms are so prolonged.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Behaviour disorder, Dizziness, Headache
Clinical narrative: Within minutes of getting vaccine complained of headache and dizziness. Watched in clinic for an extra half an hour, was stable no other complaints, thought he was feeling better so sent home. Parent and parent returned to UC on 1/19 reporting that headache continued for several day and was intermittent after that. But still happening most days. Better with Tylenol of ibuprofen, but dad was using sparingly.  Had follow up in pediatrics on 2/2. Dad reports headaches are improving  in frequency and severity But patient still complains 2-3 times a week. Mostly seems to complain during school or homework so dad is not sure if he is having pain or if it is behavioral. Is concerned as this is not a symptom he had previous to vaccine and the symptoms are so prolonged.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Patient called the pharmacy on 12-10-2021 to report that she was having itching and a rash formed.   She was advised to contact her prescriber if the symptoms got worse or changed.    She asked that we just note it in her file.   If symptoms did not improve in 24-48 hours she should see her doctor.   She did end up seeing 2 different prescribers at an Urgent Care facility and was provided prescription treatment.  On 12-13-2021 she was prescribed by HCP Zyrtec 10mg daily and Prednisone 40mg daily for 5 days.   She followed up with Dr. at the same Urgent Care on 12-20-2021 and was provided a Medrol DosePak and Atarax 25mg three times per day if needed for itching.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: A few days after my first dose, My arm was very red, upper arm, It was also several inches below the injection site. It was an inflamed, itchy warm to the touch lump and pain. I did have a very slight fever.  It was almost a week before it was completely gone. It almost looked like I was struck with something. It was a wide band across my arm.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: A few days after my first dose, My arm was very red, upper arm, It was also several inches below the injection site. It was an inflamed, itchy warm to the touch lump and pain. I did have a very slight fever.  It was almost a week before it was completely gone. It almost looked like I was struck with something. It was a wide band across my arm.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered BUD.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Severe pain in head, muscles, joints. Severe fatigue with chills and hot flashes. Air hurts my skin. When I am cold it feels like daggers piercing my skin. Nauseous. Diarrhea. Injection site tenderness. Fever up to 102.